These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14679092)

  • 1. Two cases of "fulminant" type 1 diabetes suggesting involvement of autoimmunity.
    Nakagawa Y; Shimada A; Oikawa Y; Irie J; Shigihara T; Tsumura K; Narumi S; Saruta T
    Ann N Y Acad Sci; 2003 Nov; 1005():359-61. PubMed ID: 14679092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of GAD-reactive CD4+ cells in so-called "type 1B" diabetes.
    Shimada A; Kodama K; Morimoto J; Oikawa Y; Irie J; Nakagawa Y; Matsubara K; Maruyama T; Saruta T
    Ann N Y Acad Sci; 2003 Nov; 1005():378-86. PubMed ID: 14679096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum IP-10 levels observed in type 1 diabetes.
    Shimada A; Morimoto J; Kodama K; Suzuki R; Oikawa Y; Funae O; Kasuga A; Saruta T; Narumi S
    Diabetes Care; 2001 Mar; 24(3):510-5. PubMed ID: 11289477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes.
    Cainelli F; Manzaroli D; Renzini C; Casali F; Concia E; Vento S
    Diabetes Care; 2000 Jul; 23(7):1021-2. PubMed ID: 10895859
    [No Abstract]   [Full Text] [Related]  

  • 5. T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase.
    Aoki K; Taniyama M; Nagayama C; Oikawa Y; Shimada A
    Ann N Y Acad Sci; 2006 Oct; 1079():181-5. PubMed ID: 17130552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive T cells in human type 1 diabetes.
    Tree TI; Peakman M
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):113-33, ix-x. PubMed ID: 15053898
    [No Abstract]   [Full Text] [Related]  

  • 7. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
    Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
    Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes.
    Boettler T; Pagni PP; Jaffe R; Cheng Y; Zerhouni P; von Herrath M
    J Autoimmun; 2013 Aug; 44():40-8. PubMed ID: 23770292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
    Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.
    Lohmann T; Hawa M; Leslie RD; Lane R; Picard J; Londei M
    Lancet; 2000 Jul; 356(9223):31-5. PubMed ID: 10892762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological Aspects of Fulminant Type 1 Diabetes in Chinese.
    Wang Z; Zheng Y; Tu Y; Dai Z; Lin J; Zhou Z
    J Immunol Res; 2016; 2016():1858202. PubMed ID: 26981545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell autoimmunity to glutamic acid decarboxylase in human insulin-dependent diabetes mellitus.
    Lohmann T; Scherbaum WA
    Horm Metab Res; 1996 Jul; 28(7):357-60. PubMed ID: 8858386
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotypes of anti-islet autoantibodies.
    Eisenbarth GS
    Diabetes Care; 2000 Feb; 23(2):151-2. PubMed ID: 10868822
    [No Abstract]   [Full Text] [Related]  

  • 16. The $64000 question in diabetes continues.
    Atkinson MA
    Lancet; 2000 Jul; 356(9223):4-6. PubMed ID: 10892753
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular manipulation of autoantibody testing in type 1 diabetes: two for one.
    Sacks DB; Lernmark A
    Clin Chem; 2001 May; 47(5):803-4. PubMed ID: 11325879
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large antigens such as GAD-65 become involved in pathogenic self-reactivity, but fortunately only rarely.
    Sercarz EE
    J Autoimmun; 2003 May; 20(3):203-6. PubMed ID: 12753804
    [No Abstract]   [Full Text] [Related]  

  • 20. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.
    Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A
    Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.